Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3

Farmaco

Volumn 54, Issue 3, 1999, Pages 169-177

  Sanna, Paolo ^a   Carta, Antonio ^a   Loriga, Mario ^a   Zanetti, Stefania ^a   Sechi, Leonardo ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

2 Quinoxalinones; Antibacterial; Anticancer activities; Antifungal; Antimycobacterial activities

Indexed keywords

ANTIMYCOBACTERIAL AGENT; QUINOXALINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANDIDA; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN;

ANTI-INFECTIVE AGENTS; HUMANS; MOLECULAR STRUCTURE; QUINOXALINES;

EID: 0033620470     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00011-7     Document Type: Article

References (12)

1. P. Sanna, A. Carta, M. Loriga, S. Zanetti, I. Duprè, Preparazione e valutazione microbiologica in vitro di nuovi derivati 3,4-diidrochinossalinonici variamente sostituiti, Atti XIII Convegno Nazionale della Divisione di Chimica Farmaceutica, Paestum, Italy, 23-27 Sept. 1996, Italian Chemical Society, Rome, p. 176.
2. Sanna P., Carta A., Loriga M., Zanetti S., Sechi L. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity. Farmaco. 53:1998;455-461.
3. Sanna P., Carta A., Loriga M., Zanetti S., Sechi L. Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2. Farmaco. 54:1999;161-168.
4. M. Loriga, G. Paglietti, Quinoxaline chemistry. Part 1. 6-trifluoromethylquinoxalines and their N-oxides. Synthesis and structure elucidation, J. Chem. Research (S) (1986) 16-17; J. Chem. Research (M) (1986) 277-296.
5. M. Loriga, G. Paglietti, Quinoxaline chemistry. Part 1. 6-trifluoromethylquinoxalines and their N-oxides. Synthesis and structure elucidation, J. Chem. Research (S) (1986) 16-17; J. Chem. Research (M) (1986) 277-296.
6. Abasolo M.I., Gaozza C.H., Fernandez B.M. Kinetic study on the anelation of heterocycles. 1. Quinoxalinone derivatives synthesized by Hinsberg reaction. J. Heterocyclic Chem. 24:1987;1771-1775.
7. El-Said Mustafa M., Takaoka A., Ishikawa N. Trifluoropyruvic acid hydrate in heterocyclic synthesis. Synthesis of trifluoromethylated five, six and seven membered heterocycles with two or more heteroatoms. Bull. Soc. Chim. Fr. 6:1986;944-954.
8. Baxter I., Cameron D.W. The reductive formylation of some quinoxaline derivatives. J. Chem. Soc. (C). 19:1968;2471-2474.
9. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M7-A2, Villanova, PA, USA, 1990.
10. National Committee for Clinical Laboratory Standards, Methods for determining bactericidal activity of antimicrobial agents, Tentative Guidelines, National Committee for Clinical Laboratory Standards, Document M26-T, Villanova, PA, USA, 1992.
11. Boyd M.R. Status of the NCI preclinical antitumor drug discovery screen. Principles Practice Oncol. 3:1989;1-12.
12. Weislow O.W., Kiser R., Fine D., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.